BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2155729)

  • 1. Spindle cell sarcoma showing concentration of Tc-99m sodium pertechnetate and Tc-99m (V) DMSA.
    Halkar RK; Patel MC; Khammash NF
    Clin Nucl Med; 1990 Feb; 15(2):126-7. PubMed ID: 2155729
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
    Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
    Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scintigraphic observation of cancer with 99mTc(V)-DMS].
    Ohta J; Endo K; Kotoura Y; Torizuka K
    Rinsho Hoshasen; 1984 Aug; 29(8):935-6. PubMed ID: 6096599
    [No Abstract]   [Full Text] [Related]  

  • 4. 99Tcm(V) DMSA: what is its current role in the management of patients with head and neck cancer?
    Watkinson J; Clarke S
    Nucl Med Commun; 1991 Feb; 12(2):79-82. PubMed ID: 1848360
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
    Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
    Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99Tcm (v) DMSA: the pituitary sign.
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Apr; 11(4):313-7. PubMed ID: 2163501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
    Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
    Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
    Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
    Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor imaging using Tc(V)-99m dimercaptosuccinic acid, a newly developed radiopharmaceutical: its clinical usefulness].
    Ohta H; Endo K; Koizumi M; Fujita T; Sakahara H; Nakashima T; Torizuka K; Hata N; Masuda H; Yomoda I
    Kaku Igaku; 1985 Nov; 22(11):1653-60. PubMed ID: 3007822
    [No Abstract]   [Full Text] [Related]  

  • 11. Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour model.
    Watkinson JC; Allen S; Lazarus CR; Laws D; Hibbert J; Clarke SE
    Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):497-501. PubMed ID: 1963580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological study.
    Watkinson JC; Todd CE; Lazarus CR; Maisey MN; Clarke SE
    J Laryngol Otol; 1990 Oct; 104(10):783-9. PubMed ID: 2174074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinoma.
    Watkinson JC; Allen S; Lazarus CR; Sinclair J; Blake GM; Clarke SE
    Nucl Med Commun; 1990 May; 11(5):343-59. PubMed ID: 2164650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m (V) DMSA uptake in amyloidosis.
    Ohta H; Endo K; Kanoh T; Konishi J; Kotoura H
    J Nucl Med; 1989 Dec; 30(12):2049-52. PubMed ID: 2555464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99Tcm(v)-DMSA planar scintigraphy: does it have a role in the management of patients with head and neck squamous carcinoma?
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1989 Dec; 10(12):859-70. PubMed ID: 2560154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental visualization of hepatic hemangioma during Tc-99m (v) DMSA, Tl-201, and Tc-99m MDP imaging.
    Adalet I; Kocak M; Oguz H; Alagol F; Cantez S
    Clin Nucl Med; 1995 Dec; 20(12):1106-7. PubMed ID: 8674308
    [No Abstract]   [Full Text] [Related]  

  • 19. Tc-99m(V) DMSA accumulation in thyroid amyloidosis.
    Ohta H; Hatabu H; Endo K; Fujita T; Iida Y; Kasagi K; Konishi J; Kotoura H
    Clin Nucl Med; 1991 Oct; 16(10):778-9. PubMed ID: 1660389
    [No Abstract]   [Full Text] [Related]  

  • 20. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
    Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
    Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.